Editorial Policies

Focus and Scope

Medicina Biomedica Journal is a peer-reviewed, open-access journal that publishes original research articles, review articles, and interesting case reports in the field of biomedical research aimed to publish a high-quality scientific paper including original research papers, case reports, reviews, short communication, and technical notes. This journal welcomes the submission of articles that offering a sensible transfer of basic research to applied clinical medicine. Medicina Biomedica Journal covers the latest developments in various fields of biomedicine with special attention to medical sciences, genetics, immunology, environmental health, toxicology, bioinformatics, and biotechnology as well as multidisciplinary studies.

The views of experts on current advances in biomedicals and molecular/cell biology will be also considered for publication as long as they have a direct clinical impact on human health. The journal is intended as a medium of communication for those who were interested to study health, among others, for researchers, educators, students, and the public generally who have an interest in it. The journal is trying to meet the growing need to study health and to achieve a high impact factor in the development of science and technology.


Section Policies


Checked Open Submissions Checked Indexed Checked Peer Reviewed

Peer Review Process

Review policy

The practice of peer review is intended to ensure that only good science is published. As an objective method of guaranteeing excellence in scholarly publishing, it has been adopted by all reputable scientific journals. Our referees play a vital role in maintaining the high standards of the Journal of Pragmatics, which is why all incoming manuscripts are peer-reviewed following the procedure outlined below.

Initial manuscript evaluation

One of the Editors first evaluates all submitted manuscripts. It is rare, but it is possible for an exceptional manuscript to be accepted at this stage. Manuscripts rejected at this stage are insufficiently original, have serious scientific flaws, have poor grammar or English language, or are outside the aims and scope of the journal. Those that meet the minimum criteria are normally passed on to at least two expert referees for review. Authors of manuscripts rejected at this stage will usually be informed within two weeks of receipt.

Type of peer review

The Medicina Biomedica Journal employs ‘double blind’ reviewing, in which the referees remain anonymous to the author(s) throughout and following the refereeing process, whilst the identity of the author(s) is likewise unknown to the reviewers.

Final report

A final decision to accept or reject the manuscript will be sent to the author along with the recommendations made by the referees, including (if applicable) the latter’s verbatim comments.

The Chief Editor's decision is final

Referees advise the Chief Editor, who is responsible for the final decision to accept or reject the article.


Open Access Policy

This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.